Specialty Chemicals Q3 Earnings Preview - Underlying Trend Remains Strong: ICICI Securities

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..ICICI Securities Report.We estimate our chemical coverage universe revenue to grow at 42% YoY (7% QoQ) during Q3 FY22 on sharp rise in prices due to input cost inflation. However, gross profit is also expected to grow 29% YoY which indicates strong underlying trend led by robust growth for SRF Ltd. (42.5% YoY) on pricing benefit in refrigerant-gas; and Gujarat Fluorochemicals Ltd. (60.7%) on turnaround in fluoropolymers. Rossari Biotech Ltd. (up 39%) to benefit from acquisition. Tatva Chintan Pharma Chem Ltd. and Clean Science and Technology Ltd.’s gross profit to grow steady at 25% YoY each, while Navin Fluorine International Ltd. (up 20.8%) growth is restricted on pending new capex commercialisation. Galaxy Surfactants Ltd. would see gross profit decline YoY (down 8.8%) on continued challenge from unavailability of key raw material and logistic issues. .Click on the attachment to read the full report:.DISCLAIMERThis report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Specialty Chemicals Q3 Earnings Preview - Underlying Trend Remains Strong: ICICI Securities

Specialty Chemicals Q3 Earnings Preview - Underlying Trend Remains Strong: ICICI Securities

Choose a plan